Abstract
5580Background: The PI3K/AKT/ mTOR pathway may play an important role in chemotherapy resistance in ovarian cancer. (E) is an orally administered mTOR inhibitor approved for multiple indications. T...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.